Clinical trial
Safety and Efficacy of MEM 1003 Versus Placebo for the Treatment of Patients…
NCT00374920 · Memory Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00374920 |
|---|---|
| Title | Safety and Efficacy of MEM 1003 Versus Placebo for the Treatment of Patients With Bipolar I Disorder |
| Official title | A Multicenter, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of MEM 1003 for the Treatment of Patients With Bipolar I Disorder Suffering Acute Manic or Mixed Episodes |
| Lead sponsor | Memory Pharmaceuticals, Industry |
| Collaborators | Stanley Medical Research Institute |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Bipolar Disorder With Manic or Mixed Episodes |
| Intervention type | Drug |
| Interventions | MEM 1003 |
| Enrollment | 60 |
| Start date | Sep 1, 2006 |
| Primary completion | Dec 1, 2006 |
| Completion | Mar 1, 2007 |
| First posted | Sep 12, 2006 |
| Last update posted | May 6, 2008 |
| Countries | United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: